V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20219698 | 20083715 | 1.7 | 77.6 | Palliative (P) | null | 2018-05-29 | Mitomycin Intravesical | N | N | MITOMYCIN INTRAVESICULAR | 100032021 |
| 20219699 | 20083716 | 1.7 | 69.5 | Palliative (P) | null | 2019-04-29 | Mitomycin Intravesical | N | N | MITOMYCIN INTRAVESICULAR | 100171788 |
| 20219701 | 20083717 | 1.6 | 39.7 | Adjuvant (A) | 2019-01-25 | 2019-01-25 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | CARBOPLATIN | 100400112 |
| 20219704 | 20083718 | null | 82.1 | Palliative (P) | 2020-01-17 | 2020-01-23 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101632316 |
| 20219706 | 20083719 | 1.67 | 124 | Palliative (P) | 2016-11-27 | 2016-11-29 | Enzalutamide | 02 | N | TRASTUZUMAB | 100991033 |
| 20219709 | 20083720 | 1.76 | 63 | Palliative (P) | 2019-09-25 | 2019-09-28 | Enzalutamide | 02 | N | TRASTUZUMAB | 101866397 |
| 20219711 | 20083721 | 1.75 | 84 | Palliative (P) | null | 2017-06-16 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100839939 |
| 20219713 | 20083722 | 1.53 | 89.7 | Curative (C) | 2018-11-23 | 2018-12-01 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101031632 |
| 20219714 | 20083723 | 1.63 | 128 | Palliative (P) | null | 2017-10-26 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100321831 |
| 20219717 | 20083724 | 1.72 | 106 | null | 2018-10-09 | 2018-10-10 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100235911 |
| 20219719 | 20083725 | 1.56 | null | Palliative (P) | 2016-10-15 | 2016-10-16 | Enzalutamide | N | N | TRASTUZUMAB | 100189986 |
| 20219722 | 20083726 | 1.67 | 65.2 | Curative (C) | 2010-08-07 | 2016-10-23 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100109644 |
| 20219729 | 20083727 | 1.6 | 87.2 | Curative (C) | 2018-04-05 | 2018-04-11 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100974043 |
| 20219732 | 20083728 | 1.69 | 0 | null | 2019-02-20 | 2019-02-20 | Cetuximab 14 day | 02 | null | SCALOP-2 TRIAL | 101424888 |
| 20219733 | 20083729 | 1.62 | 67 | 02 | 2016-12-29 | 2017-01-14 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100452218 |
| 20219735 | 20083730 | 1.64 | 59.8 | Curative (C) | 2018-05-05 | 2018-05-07 | Enzalutamide | 02 | Y | CARBOPLATIN + GEMCITABINE | 101788804 |
| 20219736 | 20083731 | 1.77 | 73 | Palliative (P) | 2021-06-24 | 2021-07-04 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100818125 |
| 20219737 | 20083732 | 1.76 | 55.3 | Palliative (P) | 2019-11-26 | 2019-11-26 | Enzalutamide | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101245898 |
| 20219746 | 20083733 | 1.65 | 81.75 | Palliative (P) | 2018-10-26 | 2018-10-30 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101434319 |
| 20219755 | 20083734 | 1.85 | 63.6 | null | 2018-06-10 | 2018-07-01 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 100225205 |
| 20219756 | 20083735 | 1.67 | 51.6 | Palliative (P) | 2016-03-29 | 2016-04-06 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101330366 |
| 20219758 | 20083736 | 1.7 | 66 | Disease modification (D) | 2018-08-31 | 2018-08-31 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 100625503 |
| 20219761 | 20083737 | 1.59 | 77.2 | Palliative (P) | 2016-10-30 | 2016-11-01 | Enzalutamide | 02 | N | CETUXIMAB | 101539260 |
| 20219763 | 20083738 | 1.61 | 85.7 | Palliative (P) | 2018-08-19 | 2018-08-19 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101643645 |
| 20219765 | 20083739 | 1.65 | 84.6 | Curative (C) | null | 2017-06-28 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100002978 |
| 20219766 | 20083740 | 1.58 | 73.7 | Neo-adjuvant (N) | 2019-05-14 | 2019-05-21 | Enzalutamide | N | N | CETUXIMAB + OXALIPLATIN + MDG | 100425405 |
| 20219770 | 20083741 | 1.65 | 62.3 | Curative (C) | null | 2017-02-20 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101224105 |
| 20219771 | 20083742 | 1.68 | 63.7 | Neo-adjuvant (N) | 2016-09-26 | 2016-10-01 | Enzalutamide | 02 | Y | SCALOP-2 TRIAL | 101753284 |
| 20219773 | 20083743 | 0 | 77.4 | Palliative (P) | 2017-09-12 | 2017-10-02 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101655188 |
| 20219782 | 20083744 | 1.76 | 65 | Palliative (P) | null | 2018-08-22 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100059313 |
| 20219783 | 20083745 | 1.76 | null | Palliative (P) | 2017-03-19 | 2017-03-30 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100923437 |
| 20219784 | 20083746 | 0 | 0 | Palliative (P) | 2018-09-26 | 2018-09-27 | Enzalutamide | 02 | N | ECF | 101774078 |
| 20219789 | 20083747 | 1.85 | 62.9 | Neo-adjuvant (N) | 2018-12-08 | 2019-01-06 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100858128 |
| 20219791 | 20083748 | 1.72 | 62.8 | Adjuvant (A) | 2016-03-16 | 2016-03-16 | Cisplatin | 02 | N | CARBOPLATIN + GEMCITABINE | 100413995 |
| 20219794 | 20083749 | 1.73 | 67.2 | Palliative (P) | 2019-01-01 | 2019-01-22 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 100131460 |
| 20219798 | 20083750 | 1.53 | 106.2 | Neo-adjuvant (N) | 2019-12-28 | 2020-01-17 | LUTETIUM-177 | 02 | Y | LUTETIUM-177 | 101022553 |
| 20219805 | 20083751 | 0 | 69.3 | null | 2017-06-27 | 2017-06-29 | Enzalutamide | 02 | null | CARBOPLATIN + GEMCITABINE | 100349238 |
| 20219807 | 20083752 | 0 | 0 | 03 | 2016-11-23 | 2016-12-22 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100044606 |
| 20219809 | 20083753 | null | 182.5 | null | 2019-06-15 | 2019-07-13 | Enzalutamide | N | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100348557 |
| 20219816 | 20083754 | 1.7 | 51.6 | Palliative (P) | 2018-03-03 | 2018-03-03 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100318394 |
| 20219817 | 20083755 | 1.76 | 70 | Neo-adjuvant (N) | 2018-04-12 | 2018-04-19 | Enzalutamide | 1 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101720328 |
| 20219820 | 20083756 | 1.58 | 44 | Palliative (P) | 2017-06-21 | 2017-10-01 | Enzalutamide | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100763380 |
| 20219832 | 20083757 | 1.88 | 74.45 | Palliative (P) | 2018-06-03 | 2018-06-16 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101059193 |
| 20219834 | 20083758 | 1.77 | 69.3 | null | 2019-02-20 | 2019-02-20 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 100282674 |
| 20219836 | 20083759 | 0 | 79.8 | Neo-adjuvant (N) | 2019-08-10 | 2019-08-15 | CARBOPLATIN | 02 | Y | CARBOPLATIN | 101683254 |
| 20219839 | 20083760 | 1.65 | 97.9 | Neo-adjuvant (N) | 2016-03-05 | 2016-03-23 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100962012 |
| 20219844 | 20083761 | 1.7 | 64 | Palliative (P) | 2018-09-29 | 2018-10-03 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101270383 |
| 20219846 | 20083762 | 0 | 0 | Curative (C) | 2015-10-08 | 2015-10-08 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101440403 |
| 20219848 | 20083763 | 1.74 | 98.4 | Palliative (P) | 2016-04-06 | 2016-04-07 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101328643 |
| 20219851 | 20083764 | 1.78 | 100.8 | Palliative (P) | 2016-08-15 | 2016-08-23 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100729903 |